NCT06456372 Digital Health Intervention for Children With ADHD
| NCT ID | NCT06456372 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Riverside |
| Condition | ADHD |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-02-22 |
| Primary Completion | 2027-09-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-02-22 with a primary completion date of 2027-09-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To conduct an RCT to evaluate the efficacy of the system, we will recruit 60 children (ages 8-12) with ADHD who will be randomized to either immediate (n=30) or delayed (n=30) treatment (i.e., a wait-list control group). Among those randomized to immediate treatment, half will be assigned to DHI (delivered via a smartwatch and smartphone application) and half will be assigned to an active control treatment as usual (TAU) group who will receive the smartwatch with no assigned activities, applications, or interventions on the devices. The intervention period will last 16 weeks; after a participant has been in the delayed treatment group for 16 weeks and has completed the post-waiting period assessment, he or she will be assigned to either the intervention or active control group. Thus, 30 participants will complete the intervention and 30 will complete the active control, with half of the total sample also completing a wait-list period.
Eligibility Criteria
Inclusion Criteria: 1. DSM-5TR diagnosis of ADHD through prior medical or psychological evaluations at the time of admission to the program, 2. ability to complete questionnaires and use an app in English, 3. reported IQ of at least 80 in order to ensure that the participant has the cognitive skills needed to use the app, and 4. parent/guardian available to consent and provide feedback in English. Exclusion Criteria: * Failure to meet any of the inclusion criteria
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06456372 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 12 Years, studying ADHD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06456372 currently recruiting?
Yes, NCT06456372 is actively recruiting participants. Contact the research team at jaime.smith@medsch.ucr.edu for enrollment information.
Where is the NCT06456372 trial being conducted?
This trial is being conducted at Irvine, United States, Riverside, United States.
Who is sponsoring the NCT06456372 clinical trial?
NCT06456372 is sponsored by University of California, Riverside. The trial plans to enroll 60 participants.